These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29324067)

  • 1. MAO inhibitors and their wider applications: a patent review.
    Carradori S; Secci D; Petzer JP
    Expert Opin Ther Pat; 2018 Mar; 28(3):211-226. PubMed ID: 29324067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An updated patent review on monoamine oxidase (MAO) inhibitors.
    Guglielmi P; Carradori S; D'Agostino I; Campestre C; Petzer JP
    Expert Opin Ther Pat; 2022 Aug; 32(8):849-883. PubMed ID: 35638744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential.
    Carradori S; Secci D; Bolasco A; Chimenti P; D'Ascenzio M
    Expert Opin Ther Pat; 2012 Jul; 22(7):759-801. PubMed ID: 22702491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).
    Carradori S; Petzer JP
    Expert Opin Ther Pat; 2015 Jan; 25(1):91-110. PubMed ID: 25399762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Privileged scaffolds as MAO inhibitors: Retrospect and prospects.
    Tripathi AC; Upadhyay S; Paliwal S; Saraf SK
    Eur J Med Chem; 2018 Feb; 145():445-497. PubMed ID: 29335210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold.
    Matos MJ; Viña D; Vazquez-Rodriguez S; Uriarte E; Santana L
    Curr Top Med Chem; 2012; 12(20):2210-39. PubMed ID: 23231397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Review of Monoamine Oxidase-A Inhibitors in their Syntheses and Potencies.
    Rehuman NA; Mathew B; Jat RK; Nicolotti O; Kim H
    Comb Chem High Throughput Screen; 2020; 23(9):898-914. PubMed ID: 32342809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focusing on new monoamine oxidase inhibitors.
    Bolasco A; Carradori S; Fioravanti R
    Expert Opin Ther Pat; 2010 Jul; 20(7):909-39. PubMed ID: 20553094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the detailed structure-activity relationship of coumarins as Monoamine oxidase enzyme inhibitors-An updated review.
    Koyiparambath VP; Prayaga Rajappan K; Rangarajan TM; Al-Sehemi AG; Pannipara M; Bhaskar V; Nair AS; Sudevan ST; Kumar S; Mathew B
    Chem Biol Drug Des; 2021 Oct; 98(4):655-673. PubMed ID: 34233082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?
    Guglielmi P; Carradori S; Ammazzalorso A; Secci D
    Expert Opin Drug Discov; 2019 Oct; 14(10):995-1035. PubMed ID: 31268358
    [No Abstract]   [Full Text] [Related]  

  • 11. Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.
    Gaspar A; Reis J; Fonseca A; Milhazes N; Viña D; Uriarte E; Borges F
    Bioorg Med Chem Lett; 2011 Jan; 21(2):707-9. PubMed ID: 21194943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibition by selected dye compounds.
    de Beer F; Petzer JP; Petzer A
    Chem Biol Drug Des; 2020 Mar; 95(3):355-367. PubMed ID: 31834986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
    Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
    Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of monoamine oxidase inhibitors in chronic neurodegeneration.
    Riederer P; Müller T
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):233-240. PubMed ID: 27998194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
    Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review.
    Mathew B; Mathew GE; Petzer JP; Petzer A
    Comb Chem High Throughput Screen; 2017; 20(6):522-532. PubMed ID: 28245770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.
    Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A
    Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update.
    Tripathi RKP; Ayyannan SR
    Med Res Rev; 2019 Sep; 39(5):1603-1706. PubMed ID: 30604512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
    Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
    Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.